Results 251 to 257 of about 86,485 (257)

Beneficial effect of tocilizumab in myasthenia gravis refractory to rituximab

Neuromuscular Disorders, 2017
Fredrik Piehl, Ritva Pirskanen
exaly  

The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab

Rheumatology, 2010
Masashi Narazaki, Tadamitsu Kishimoto
exaly  

Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family

International Immunopharmacology, 2005
Shigeto Kawai, Yoshiyuki Ohsugi, Masahiko Mihara   +2 more
exaly  

Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis

Rheumatology, 2019
Paul Emery, Anne Paccaly, Neil M H Graham   +2 more
exaly  

Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti–IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease

Blood, 2008
exaly  

Tocilizumab: The first interleukin-6-receptor inhibitor

American Journal of Health-System Pharmacy, 2008
exaly  

Update on tocilizumab in rheumatoid arthritis: a narrative review

Frontiers in Immunology
Francesco Ghellere, Enrico Fusaro, Richard Borrelli   +2 more
exaly